Submit your research
Start your submission and get more impact for your research by publishing with us.
Part of the largest and most cited immunology journal, this section explores allogenic hematopoietic stem cell transplantation (HSCT) as a cellular immunotherapy.
Start your submission and get more impact for your research by publishing with us.
Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.
Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.
Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days.
Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.
Fred Hutchinson Cancer Center
Seattle, United States
Specialty Chief Editor
Alloimmunity and Transplantation
Université Paris Cité
Paris, France
Specialty Chief Editor
Alloimmunity and Transplantation
University of Ulm
Ulm, Germany
Associate Editor
Alloimmunity and Transplantation
Mario Negri Institute for Pharmacological Research (IRCCS)
Milano, Italy
Associate Editor
Alloimmunity and Transplantation
Original Research
Published on 16 Apr 2025
in Alloimmunity and Transplantation
Original Research
Published on 16 Apr 2025
in Alloimmunity and Transplantation
Review
Accepted on 15 Apr 2025
in Alloimmunity and Transplantation
Brief Research Report
Accepted on 15 Apr 2025
in Alloimmunity and Transplantation
Submission open
Submission open
Submission open
Submission open